Meta-analysis revealed that BRAF mutation is associated with lymph node metastasis, tumor stage, extrathyroidal extension, tumor size, and classic PTC (Li et al. 2012). The gene discussed is BRAF; the disease is metastatic malignant neoplasm in the lymph nodes.